Back to search

Article

Aclarubicin disrupts RNA polymerase II progression at replication-coupled histone genes

2026-07-09

Abstract excerpt

Anthracyclines are highly effective chemotherapeutic agents that cause DNA and chromatin damage. One member of the anthracyclines, aclarubicin, has recently gained therapeutic interest due to its ability to kill cancer cells through chromatin-based mechanisms, thus avoiding the off-target effects associated with DNA damage. Despite this, the molecular mechanism of action leading to aclarubicin-induced chromatin da...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
02e4f1e8-11b0-57d4-abac-342ab06e0d0b
DOI
10.64898/2026.07.08.737292
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 11 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Aclarubicin disrupts RNA polymerase II progression at replication-coupled histone genesDOI 10.64898/2026.07.08.737292
Select a neighboring publication to make it the new centre.